Early diagnosis of disease, targeted therapies, regenerative medicine.

Tuesday September 7^th, 2010: 11:30 – 13:00

Biomedical applications of nanotechnology can provide significant benefits for patients, for example by allowing earlier detection and diagnosis of diseases and by providing better targeted therapies with fewer side-effects. At the same time, cost savings for the healthcare system are also expected. The European Technology Platform for Nanomedicine plays an important role in identifying these opportunities and stimulating the creation of public-private research consortia. This session will give an overview of the opportunities with examples of the new possibilities offered by nanotechnology. 

Chair

• Bertrand Loubaton, Director GE Healthcare Europe (France)

Speakers

• Anders Høgset, PCI Biotech AS (Norway)
• Kevin Shakesheff, Professor of Drug Delivery & Tissue Engineering, University of Nottingham (UK)
• Emo Chiellini, University of Pisa, Dept. Of Chemistry & Industrial Chemistry (Italy)